- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 5/08 - Tripeptides
Détention brevets de la classe C07K 5/08
Brevets de cette classe: 690
Historique des publications depuis 10 ans
|
31
|
42
|
32
|
36
|
30
|
27
|
27
|
18
|
22
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Purdue Research Foundation | 3776 |
28 |
| Bristol-myers Squibb Company | 4795 |
15 |
| ISP Investments Inc. | 453 |
15 |
| Ajinomoto Co., Inc. | 2302 |
9 |
| Hoffmann-La Roche Inc. | 3602 |
8 |
| The Regents of the University of California | 20355 |
8 |
| Onyx Therapeutics, Inc. | 68 |
8 |
| Regeneron Pharmaceuticals, Inc. | 4505 |
8 |
| Genentech, Inc. | 4040 |
7 |
| Novartis AG | 10494 |
6 |
| DSM IP Assets B.V. | 5479 |
6 |
| Novozymes A/S | 3344 |
6 |
| Merck Sharp & Dohme LLC | 3751 |
6 |
| Boehringer Ingelheim International GmbH | 4595 |
5 |
| Agency for Science, Technology and Research | 3665 |
5 |
| InterMune, Inc. | 48 |
5 |
| Rhythm Pharmaceuticals, Inc. | 84 |
5 |
| Obschestvo S Ogranichennoi Otvetstvennostyu "SIA Peptides" | 6 |
5 |
| California Institute of Technology | 4006 |
4 |
| University of Florida Research Foundation, Inc. | 4110 |
4 |
| Autres propriétaires | 527 |